| Title: | Integrated lifestyle management to mitigate MASLD risk in patients with chronic kidney disease: a prospective cohort study |
| Journal: | Journal of Translational Medicine |
| Published: | 4 Mar 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41782035/ |
| DOI: | https://doi.org/10.1186/s12967-026-07901-z |
| URL: | http://dx.doi.org/10.1186/s12967-026-07901-z |
Publication 17504
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
ObjectivesThis study aimed to investigate whether effective management of multiple lifestyle risk factors could mitigate the elevated risk of metabolic dysfunction-associated steatotic liver disease (MASLD) among individuals with chronic kidney disease (CKD).MethodsWe analyzed data from the UK Biobank, including 9,877 patients with CKD and 421,043 non-CKD controls, with follow-up through October 31, 2022. Eight lifestyle-related MASLD risk factors (body mass index, diet, physical activity, alcohol consumption, smoking, social connection, sedentary behavior, and sleep duration) were assessed and jointly summarized to reflect the degree of lifestyle risk factor management. Cox proportional hazards models were used to evaluate associations between cumulative lifestyle risk factor management and incident MASLD. Effect modification by sex, type 2 diabetes (T2D), hyperlipidemia, and hypertension was examined using multiplicative interaction terms. All models were adjusted for a comprehensive set of covariates. Missing data were handled using multiple imputation with chained equations, and several sensitivity analyses were conducted to test the robustness.ResultsAmong individuals with CKD, progressively better joint management of lifestyle risk factors was associated with a stepwise reduction in incident MASLD risk. Each additional lifestyle risk factor managed was associated with a 14% lower risk of MASLD. Optimal lifestyle risk factor control (≥ 7 factors managed) was associated with a 64% reduction in MASLD (HR: 0.36; 95% CI: 0.16-0.79). Notably, among CKD patients achieving optimal lifestyle control MASLD risk was attenuated to a level comparable to that of non-CKD controls (HR: 0.95; 95% CI: 0.49-1.84). The protective association of combined lifestyle risk factor management was less pronounced in individuals with hyperlipidemia or T2D compared to those without these conditions (P for interaction < 0.001).ConclusionsIn individuals with CKD, cumulative adherence to optimal lifestyle risk factor management exhibited an inverse association with MASLD development. These findings suggest that comprehensive control of modifiable lifestyle risks may be associated with a mitigation of the elevated MASLD susceptibility observed in CKD populations.</p>
7 Authors
- Chao Yan
- Xinxin Shen
- Shaojie Han
- Jinzheng He
- Tongxu Wang
- Xiaobing Gong
- Jindong Ding Petersen
1 Application
| Application ID | Title |
|---|---|
| 300908 | Cardiovascular-kidney-metabolic health and all-cause and cause-specific mortality in the UK Biobank cohort |
Enabling scientific discoveries that improve human health